Sleep, Narcolepsy, and Sodium Oxybate

Overview

Journal Curr Neuropharmacol

Publisher Bentham Science Publishers

Date 2021 Apr 8

PMID 33827411

Citations 4

Authors

Mortimer Mamelak

Affiliations

Soon will be listed here.

Abstract

Sodium oxybate (SO) has been in use for many decades to treat narcolepsy with cataplexy. It functions as a weak GABAB agonist but also as an energy source for the brain as a result of its metabolism to succinate and as a powerful antioxidant because of its capacity to induce the formation of NADPH. Its actions at thalamic GABAB receptors can induce slow-wave activity, while its actions at GABAB receptors on monoaminergic neurons can induce or delay REM sleep. By altering the balance between monoaminergic and cholinergic neuronal activity, SO uniquely can induce and prevent cataplexy. The formation of NADPH may enhance sleep's restorative process by accelerating the removal of the reactive oxygen species (ROS), which accumulate during wakefulness. SO improves alertness in normal subjects and in patients with narcolepsy. SO may allay severe psychological stress - an inflammatory state triggered by increased levels of ROS and characterized by cholinergic supersensitivity and monoaminergic deficiency. SO may be able to eliminate the inflammatory state and correct the cholinergic/ monoaminergic imbalance.

Citing Articles

Comparative efficacy of sodium oxybate versus placebo on improvement of nighttime sleep in adult patients with narcolepsy: A systematic review and meta-analysis.

Arshad A, Qureshi M, Masood M, Zahoor H, Nazakat A, Fatima A Sleep Med X. 2025; 9():100136.

PMID: 39811427 PMC: 11728066. DOI: 10.1016/j.sleepx.2024.100136.

Bibliometric and visual study of narcolepsy from 2000 to 2023.

Yang C, Sun L, Wang S, Li H, Zhang K World J Psychiatry. 2024; 14(12):1971-1981.

PMID: 39704374 PMC: 11622029. DOI: 10.5498/wjp.v14.i12.1971.

Depression and the Glutamate/GABA-Glutamine Cycle.

Mamelak M Curr Neuropharmacol. 2024; 23(1):75-84.

PMID: 39150032 PMC: 11519819. DOI: 10.2174/1570159X22666240815120244.

Summary of drug therapy to treat cognitive impairment-induced obstructive sleep apnea.

He D, Chen J, Du X, Xu L Front Cell Neurosci. 2023; 17:1222626.

PMID: 37731463 PMC: 10507626. DOI: 10.3389/fncel.2023.1222626.

Sodium oxybate-a new horizon for symptomatic treatment of RBD?.

Stefani A, Hogl B, Videnovic A Sleep. 2023; 46(8).

PMID: 37232455 PMC: 10424167. DOI: 10.1093/sleep/zsad150.

References

BOEHME R, Baker T, Mefford I, Barchas J, Dement W, Ciaranello R . Narcolepsy: cholinergic receptor changes in an animal model. Life Sci. 1984; 34(19):1825-8. DOI: 10.1016/0024-3205(84)90675-1. View

Zhong P, Zhang Z, Barger Z, Ma C, Liu D, Ding X . Control of Non-REM Sleep by Midbrain Neurotensinergic Neurons. Neuron. 2019; 104(4):795-809.e6. DOI: 10.1016/j.neuron.2019.08.026. View

Denis D, French C, Gregory A . A systematic review of variables associated with sleep paralysis. Sleep Med Rev. 2017; 38:141-157. DOI: 10.1016/j.smrv.2017.05.005. View

Li S, De Lecea L . The hypocretin (orexin) system: from a neural circuitry perspective. Neuropharmacology. 2020; 167:107993. DOI: 10.1016/j.neuropharm.2020.107993. View

Toossi H, Del Cid-Pellitero E, Jones B . Homeostatic regulation through GABA and acetylcholine muscarinic receptors of motor trigeminal neurons following sleep deprivation. Brain Struct Funct. 2017; 222(7):3163-3178. PMC: 5585289. DOI: 10.1007/s00429-017-1392-4. View

Tatsuki F, Sunagawa G, Shi S, Susaki E, Yukinaga H, Perrin D . Involvement of Ca(2+)-Dependent Hyperpolarization in Sleep Duration in Mammals. Neuron. 2016; 90(1):70-85. DOI: 10.1016/j.neuron.2016.02.032. View

Andrada J, Livingston P, Lee B, Antognini J . Propofol and etomidate depress cortical, thalamic, and reticular formation neurons during anesthetic-induced unconsciousness. Anesth Analg. 2011; 114(3):661-9. DOI: 10.1213/ANE.0b013e3182405228. View

Black J, Houghton W . Sodium oxybate improves excessive daytime sleepiness in narcolepsy. Sleep. 2006; 29(7):939-46. DOI: 10.1093/sleep/29.7.939. View

Oshima T, Karasawa F, Okazaki Y, Wada H, Satoh T . Effects of sevoflurane on cerebral blood flow and cerebral metabolic rate of oxygen in human beings: a comparison with isoflurane. Eur J Anaesthesiol. 2003; 20(7):543-7. DOI: 10.1017/s0265021503000863. View

10.

Wang H, Kuo Z, Fu Y, Chen R, Min M, Yang H . GABAB receptor-mediated tonic inhibition regulates the spontaneous firing of locus coeruleus neurons in developing rats and in citalopram-treated rats. J Physiol. 2015; 593(1):161-80. PMC: 4293061. DOI: 10.1113/jphysiol.2014.281378. View

11.

Nelson A, Faraguna U, Tononi G, Cirelli C . Effects of anesthesia on the response to sleep deprivation. Sleep. 2010; 33(12):1659-67. PMC: 2982736. DOI: 10.1093/sleep/33.12.1659. View

12.

Shichino T, Murakawa M, Adachi T, Arai T, Miyazaki Y, Mori K . Effects of inhalation anaesthetics on the release of acetylcholine in the rat cerebral cortex in vivo. Br J Anaesth. 1998; 80(3):365-70. DOI: 10.1093/bja/80.3.365. View

13.

Rosenberg P, Li Y, Le M, Zhang Y . Nitric oxide-stimulated increase in extracellular adenosine accumulation in rat forebrain neurons in culture is associated with ATP hydrolysis and inhibition of adenosine kinase activity. J Neurosci. 2000; 20(16):6294-301. PMC: 6772587. View

14.

Borbely A . A two process model of sleep regulation. Hum Neurobiol. 1982; 1(3):195-204. View

15.

Lehmann M, Weigel T, Poffenberger C, Herkenham M . The Behavioral Sequelae of Social Defeat Require Microglia and Are Driven by Oxidative Stress in Mice. J Neurosci. 2019; 39(28):5594-5605. PMC: 6616288. DOI: 10.1523/JNEUROSCI.0184-19.2019. View

16.

Walsh J, Hall-Porter J, Griffin K, Dodson E, Forst E, Curry D . Enhancing slow wave sleep with sodium oxybate reduces the behavioral and physiological impact of sleep loss. Sleep. 2010; 33(9):1217-25. PMC: 2938863. DOI: 10.1093/sleep/33.9.1217. View

17.

Alkire M, Haier R, Barker S, Shah N, Wu J, Kao Y . Cerebral metabolism during propofol anesthesia in humans studied with positron emission tomography. Anesthesiology. 1995; 82(2):393-403; discussion 27A. DOI: 10.1097/00000542-199502000-00010. View

18.

Erhardt S, Andersson B, Nissbrandt H, Engberg G . Inhibition of firing rate and changes in the firing pattern of nigral dopamine neurons by gamma-hydroxybutyric acid (GHBA) are specifically induced by activation of GABA(B) receptors. Naunyn Schmiedebergs Arch Pharmacol. 1998; 357(6):611-9. DOI: 10.1007/pl00005215. View

19.

Mamelak M, ESCRIU J, Stokan O . The effects of gamma-hydroxybutyrate on sleep. Biol Psychiatry. 1977; 12(2):273-88. View

20.

Takakusaki K, Takahashi K, Saitoh K, Harada H, Okumura T, Kayama Y . Orexinergic projections to the cat midbrain mediate alternation of emotional behavioural states from locomotion to cataplexy. J Physiol. 2005; 568(Pt 3):1003-20. PMC: 1464186. DOI: 10.1113/jphysiol.2005.085829. View